These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25221771)

  • 1. Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients.
    Kalantari S; Naghipour M
    Adv Biomed Res; 2014; 3():168. PubMed ID: 25221771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage).
    Han KH; Rha SW; Kang HJ; Bae JW; Choi BJ; Choi SY; Gwon HC; Bae JH; Hong BK; Choi DH; Han KR
    J Clin Lipidol; 2012; 6(4):340-51. PubMed ID: 22836071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.
    Chalasani N; Aljadhey H; Kesterson J; Murray MD; Hall SD
    Gastroenterology; 2004 May; 126(5):1287-92. PubMed ID: 15131789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea.
    Kim HS; Lee SH; Kim H; Lee SH; Cho JH; Lee H; Yim HW; Kim SH; Choi IY; Yoon KH; Kim JH
    J Clin Pharm Ther; 2016 Jun; 41(3):266-72. PubMed ID: 27015878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of MK615 for the treatment of patients with liver disorders.
    Hokari A; Ishikawa T; Tajiri H; Matsuda T; Ishii O; Matsumoto N; Okuse C; Takahashi H; Kurihara T; Kawahara K; Maruyama I; Zeniya M
    World J Gastroenterol; 2012 Aug; 18(31):4118-26. PubMed ID: 22919243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Pose E; Napoleone L; Amin A; Campion D; Jimenez C; Piano S; Roux O; Uschner FE; de Wit K; Zaccherini G; Alessandria C; Angeli P; Bernardi M; Beuers U; Caraceni P; Durand F; Mookerjee RP; Trebicka J; Vargas V; Andrade RJ; Carol M; Pich J; Ferrero J; Domenech G; Llopis M; Torres F; Kamath PS; Abraldes JG; Solà E; Ginès P
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):31-41. PubMed ID: 31607677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels.
    Tikkanen MJ; Fayyad R; Faergeman O; Olsson AG; Wun CC; Laskey R; Kastelein JJ; Holme I; Pedersen TR;
    Int J Cardiol; 2013 Oct; 168(4):3846-52. PubMed ID: 24001698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A descriptive analysis of aspartate and alanine aminotransferase rise and fall following acetaminophen overdose.
    Curtis RM; Sivilotti ML
    Clin Toxicol (Phila); 2015 Nov; 53(9):849-55. PubMed ID: 26294195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervention Effects of Atorvastatin Combined with
    Jiang QF; Huang MY; Wu KY; Weng JL; Deng RG; Xu XJ; Xu JP; Jiang T
    Pharmacogn Mag; 2017; 13(51):430-438. PubMed ID: 28839368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B.
    Hung KY; Lee KC; Yen CJ; Wu KD; Tsai TJ; Chen WY
    Nephrol Dial Transplant; 1997 Jan; 12(1):180-3. PubMed ID: 9157333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of the serum alanine aminotransferase upper normal limit in chronic hepatitis C patients.
    Yagura M; Tanaka A; Kamitsukasa H; Otsuka H; Kanno S; Aoyama T
    Intern Med; 2010; 49(6):525-8. PubMed ID: 20228585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.
    Athyros VG; Tziomalos K; Gossios TD; Griva T; Anagnostis P; Kargiotis K; Pagourelias ED; Theocharidou E; Karagiannis A; Mikhailidis DP;
    Lancet; 2010 Dec; 376(9756):1916-22. PubMed ID: 21109302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
    Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
    Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary and Serum Aspartate Aminotransferases and Alanine Aminotransferases in Insulin-Dependent Diabetes Mellitus and Normal Children: A Comparative Study.
    Vinod KS; Madathil LP; Shetty P; Kaur H; Patel M; Gouraha A
    J Int Soc Prev Community Dent; 2018; 8(3):229-234. PubMed ID: 29911060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin liver safety in non-alcoholic fatty liver disease: A systematic review and metanalysis.
    Pastori D; Pani A; Di Rocco A; Menichelli D; Gazzaniga G; Farcomeni A; D'Erasmo L; Angelico F; Del Ben M; Baratta F
    Br J Clin Pharmacol; 2022 Feb; 88(2):441-451. PubMed ID: 34133035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttraumatic levels of liver enzymes can reduce the need for CT in children: a retrospective cohort study.
    Bruhn PJ; Østerballe L; Hillingsø J; Svendsen LB; Helgstrand F
    Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):104. PubMed ID: 27561373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.
    Castaño G; Fernández L; Mas R; Illnait J; Mesa M; Fernández JC
    Clin Drug Investig; 2003; 23(10):639-50. PubMed ID: 17535079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A six-month, multicenter, open-label, noncomparative, prospective, observational study of the efficacy and tolerability of atorvastatin in the primary care setting(estudio del control de las hiperlipidemiasen atención primaria): the cheap study.
    Gómez-Gerique JA; Alvarez-Sala LA; Armada B; Fernández-Arias I; Martinez J; Hernández G;
    Curr Ther Res Clin Exp; 2003 Jun; 64(6):338-54. PubMed ID: 24944383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity of Statins as Determined by Serum Alanine Aminotransferase in a Pediatric Cohort With Dyslipidemia.
    Desai NK; Mendelson MM; Baker A; Ryan HH; Griggs S; Boghani M; Yellen E; Buckley L; Gillman MW; Zachariah JP; Graham D; Jonas MM; de Ferranti SD
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):175-181. PubMed ID: 30334928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.